WiseGuyReports has announced the addition of a new intelligence report, titled “Epigenetics – Global Market Outlook (2017-2023)”.
According to research report, the Global Epigenetics Market is accounted for $752.8 million in 2016 and expected to grow at a CAGR of 14.0% to reach $1891.9 million by 2023. Growing prevalence of cancer and other chronic diseases are helping the market to compete across the globe. Some of the major factors that are influencing the market include growing technological advancements, rising R&D expenditure, growing usage for non-oncology diseases, improving collaborations between pharmaceutical, biotechnology companies & academic research institutes and increasing geriatric population base. However, huge equipment cost, lack of predictive markers, inefficiency in identification and validation of biomarkers, presence of complicated regulatory framework and shortage of skilled professional are hampering the market growth.
Based on Technology, DNA methylation can be classified as hyper and hypomethylation. Reduced representation bisulfite sequencing (RRBS) is a DNA wide methylation analysis technique for a combination of enrichment and modifying techniques. DNA methylation is also used as a biomarker for early cancer diagnosis. The FDA-approved epigenetic drugs are demethylating agents, and most of the diagnostic activity to date in epigenetics has focused on methylation markers.
Based on End User, with in the pharmaceutical sector, the therapeutic applications of epigenetics have fascinated a large and growing number of pharmaceutical and biopharmaceutical companies. Over 40 companies that are now active. Venture capital-funded companies in epigenetics include Constellation Pharmaceuticals and Syndax Pharmaceuticals.
North America dominated the overall revenue, due to the, increasing funds for R&D, growing collaborations between large pharmaceutical firms and demand for epigenetic drugs and diagnostic technologies. However, Asia-Pacific is anticipated to grow rapidly, due to high incidence of cancer, large prevalence of target diseases and rise in healthcare expenditure.
Some of the key players in Global Epigenetics market are Celgene Corporation, CellCentric Ltd, Chroma Therapeutics Ltd, Covaris Inc, DIAGENODE, INC., Ribimed Biotechnologies, Epigenomics AG, Epitherapeutics, Epizyme, Karus Therapeutics, Merck Millipore, Novartis International AG, Oncolys Biopharma Inc, OncoMethylome Sciences, Qiagen, Sigma-Aldrich Corporation, Syndax Pharmaceuticals and ZYMO RESEARCH CORPORATION (ZYMO).
Request Sample Report at https://www.wiseguyreports.com/sample-request/2768986-epigenetics-global-market-outlook-2017-2023
Products Covered:
- Enzymes
- Reagents
- Kits
- Instruments and Consumables
Technologies Covered:
- Histone Methylation
- DNA Methylation
- Histone Acetylation
- Large noncoding RNA
- Chromatin structures
- MicroRNA Modification
- Other Technologies
Applications Covered:
- Cardiovascular Diseases
- Developmental Biology
- Immunology
- Metabolic Diseases
- Inflammatory Disease
- Oncology
- Other Applications
End Users Covered:
- Pharmaceutical
- Contract Research Organizations
- Academic and Research Institutes
- Biotechnology Companies
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
- South America
o Argentina
o Brazil
o Chile
o Rest of South America
- Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements
Table of Content
1 Executive Summary
2 Preface
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Epigenetics Market, By Product
6 Global Epigenetics Market, By Technology
7 Global Epigenetics Market, By Application
8 Global Epigenetics Market, By End User
9 Global Epigenetics Market, By Geography
10 Key Developments
11 Company Profiling
11.1 Celgene Corporation
11.2 CellCentric Ltd
11.3 Chroma Therapeutics Ltd,
11.4 Covaris Inc
11.5 DIAGENODE, INC.
11.6 Ribimed Biotechnologies
11.7 Epigenomics AG
11.8 Epitherapeutics
11.9 Epizyme
11.10 Karus Therapeutics
11.11 Merck Millipore
11.12 Novartis International AG
11.13 Oncolys Biopharma Inc
11.14 OncoMethylome Sciences
11.15 Qiagen
11.16 Sigma-Aldrich Corporation
11.17 Syndax Pharmaceuticals
11.18 ZYMO RESEARCH CORPORATION (ZYMO)
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Your information will never be shared with any third party.